Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
4.370
-0.630 (-12.60%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
84,077
Open
4.810
Bid (Size)
4.170 (1)
Ask (Size)
4.550 (1)
Prev. Close
5.000
Today's Range
4.100 - 4.920
52wk Range
0.2200 - 5.070
Shares Outstanding
16,978,703
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
April 25, 2024
Via
ACCESSWIRE
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 24, 2024
Via
Benzinga
Performance
YTD
+604.73%
+604.73%
1 Month
+921.03%
+921.03%
3 Month
+602.57%
+602.57%
6 Month
+426.82%
+426.82%
1 Year
+337.04%
+337.04%
More News
Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 24, 2024
Via
InvestorPlace
Recap: Applied DNA Sciences Q1 Earnings
February 08, 2024
Via
Benzinga
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
February 08, 2024
Via
ACCESSWIRE
Applied DNA Announces 1-For-20 Reverse Stock Split
April 22, 2024
Via
ACCESSWIRE
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
April 09, 2024
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Earnings Scheduled For February 8, 2024
February 08, 2024
Via
Benzinga
Earnings Preview For Applied DNA Sciences
February 07, 2024
Via
Benzinga
Applied DNA Sciences: Q4 Earnings Insights
December 07, 2023
Via
Benzinga
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 07, 2023
Via
ACCESSWIRE
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
March 18, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
March 14, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
February 05, 2024
Via
ACCESSWIRE
Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 31, 2024
Via
Benzinga
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14, 2023
Via
ACCESSWIRE
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
December 08, 2023
Via
Benzinga
APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023
December 07, 2023
Via
InvestorPlace
Earnings Scheduled For December 7, 2023
December 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.